US Stem Cell Inc (USRM)

[Barinvest]

The matter being to further the company's position for completion of trials, which is a strict requirement of the FDA. U.S. Stem Cell is concerned with a major organ for which there can be no mistake or uncertainty regarding its therapy! The FDA is justified in its requirements to have further evidence forwarded. The evidence that U.S. Stem Cell has thus far for its Myocell product is compelling. The Company is in its infancy and has made a wise choice in generating more capital. I personally feel U.S. Stem Cell will further the efficacy of Myocell. Needless to say, given the company's progression to date, this is a wise investment!

Warmest regards,

BAR